Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies Inc (IRTC, Financial), has sold 24,701 shares of the company on February 29, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $121.96 per share, for a total value of $3,011,579.96.
iRhythm Technologies Inc is a healthcare company that provides ambulatory electrocardiogram (ECG) monitoring for patients with arrhythmias or other heart rhythm disorders. The company's technology platform, Zio, offers wearable biosensor devices for continuous monitoring and data management and analysis solutions.
Over the past year, the insider has engaged in multiple transactions, selling a total of 24,701 shares and purchasing 9,755 shares. The recent sale by the insider is part of a broader trend observed within the company. In the past year, there has been a total of 1 insider buy and 15 insider sells.
On the valuation front, iRhythm Technologies Inc's shares were trading at $121.96 on the day of the insider's recent transaction, resulting in a market cap of $3.733 billion.
The stock's price-to-GF-Value ratio stands at 0.88, indicating that iRhythm Technologies Inc is modestly undervalued according to the GF Value. The GF Value is an intrinsic value estimate that considers historical trading multiples, a GuruFocus adjustment factor based on the company's past performance, and future business performance estimates from Morningstar analysts.
The insider trend image above reflects the recent insider selling and buying activities at iRhythm Technologies Inc.
The GF Value image provides a visual representation of the stock's current valuation in relation to its intrinsic value, as estimated by GuruFocus.
Investors and stakeholders in iRhythm Technologies Inc may consider monitoring insider transactions as part of their due diligence process, as insider trading activity can provide insights into a company's internal perspective on current stock valuations.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
